The OECD Science, Technology and Industry Outlook 2012 presents, in a series of country profiles, the main features, strengths and weaknesses of national STI systems and major recent changes in national STI policy. The statistical dimension of the country profiles has drawn on the work and empirical research conducted by the OECD on the measurement of innovation and the development of internationally comparable STI indicators for policy analysis.
OECD Directorate for Science, Technology and Industry
Country Studies and Outlook Division (CSO)
(email: sti.contact@oecd.org)
Last update: June 2012.
See OECD Science, Technology and Industry Outlook 2012 Reader's guide and Methodological annex.
OECD Science, Technology and Industry Outlook 2012.
Normalised index of performance relative to the median values in the OECD area (Index median = 100).
OECD countries: Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States.
Non-member economies: Argentina, Brazil, China, Colombia, Egypt, India, Indonesia, Russian Federation, South Africa.
The performance of a country’s national innovation systems as compared to all OECD countries is represented in Panel 1 of the country profiles of the OECD Science, Technology and Industry Outlook 2012. A standard set of indicators is used to:
i) describe the competences and capacity of the science base and the business sector to innovate, as well as the framework conditions for entrepreneurship;
ii) provide some insights on interactions between STI actors via the deployment and use of the Internet and their participation in domestic and international co-operation networks; and
iii) depict the status of the human resources pool and prospects for increasing human capital further through inflows of new science and technology talent.
Indicators are normalised (by GDP or population) to take account of the size of the country.
The OECD Science, Technology and Industry Outlook 2012 presents, in a series of country profiles, the main features, strengths and weaknesses of national STI systems and major recent changes in national STI policy. The statistical dimension of the country profiles has drawn on the work and empirical research conducted by the OECD on the measurement of innovation and the development of internationally comparable STI indicators for policy analysis.
OECD Directorate for Science, Technology and Industry
Country Studies and Outlook Division (CSO)
(email: sti.contact@oecd.org)
OECD Science, Technology and Industry Outlook 2012.
See OECD Science, Technology and Industry Outlook 2012 Reader's guide and Methodological annex.
Last update: June 2012.
Normalised index of performance relative to the median values in the OECD area (Index median = 100).
OECD countries: Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States.
Non-member economies: Argentina, Brazil, China, Colombia, Egypt, India, Indonesia, Russian Federation, South Africa.
The performance of a country’s national innovation systems as compared to all OECD countries is represented in Panel 1 of the country profiles of the OECD Science, Technology and Industry Outlook 2012. A standard set of indicators is used to:
i) describe the competences and capacity of the science base and the business sector to innovate, as well as the framework conditions for entrepreneurship;
ii) provide some insights on interactions between STI actors via the deployment and use of the Internet and their participation in domestic and international co-operation networks; and
iii) depict the status of the human resources pool and prospects for increasing human capital further through inflows of new science and technology talent.
Indicators are normalised (by GDP or population) to take account of the size of the country.